Rpharmy Overhauls BlackboxRX User Experience, Interface

Medication Safety Solution Provider Significantly Upgrades Only Comprehensive Online Database of Medication Boxed Warnings

AUSTIN, Texas–(BUSINESS WIRE)–#USP800Rpharmy, a leading provider of medical formulary management and hazardous drug safety information software solutions, today announced a significant upgrade to the user experience (UX) of its BlackboxRX solution, the only online comprehensive database of medication boxed safety warnings. As part of an extensive UX upgrade to all Rpharmy solutions, BlackboxRX is the first to undergo the in-depth enhancement to its form and function.


“Twenty years ago, we introduced BlackboxRX in response to a customer’s critical need for managing black box warnings. Recognized consistently as a trusted source for essential drug safety information, we believed it was crucial to modernize its aesthetic and usability to better serve today’s healthcare professionals,” said Laura Paxton, Rpharmy CEO and Founder. “The upgraded BlackboxRX features a completely redesigned interface that’s intuitive to use, a more efficient search process, and new functionalities that empower healthcare providers to access crucial drug safety information instantly and effortlessly.”

BlackboxRX has undergone a comprehensive redesign featuring the following innovations to user experience:

Simplified Discovery: Easily locate drugs by therapeutic class via a new, prominently placed link on the BlackboxRX homepage.

Expanded Safety Information: Selecting a drug now provides users with enriched safety information, including accessible links to essential resources like patient counseling aids, REMS, package inserts, and critical FDA drug safety updates.

Enhanced Search Capabilities: The BlackboxRX search bar now features intelligent auto-fill capabilities. As users type a drug name, all related instances dynamically populate, offering seamless navigation either through specific warning information or by therapeutic class.

New Homepage Resources: The new BlackboxRX homepage now prominently displays the most recent drug warnings along with their publication dates. Additionally, users can easily access a list of the top five most frequently viewed warnings, keeping healthcare professionals informed of the most critical and sought-after safety information.

Rpharmy’s hazardous drug safety platform, Rhazdrugs, and the medication safety database, Formweb, are also undergoing a user experience redesign. The new versions of the SaaS solutions will be available later in 2024.

About Rpharmy

For more than 30 years, Rpharmy has been solving problems related to medication safety and patient care. We develop and provide technology focused on medical formulary, hazardous drug handling, and HFAP, NIOSH and Joint Commission compliance. Our primary desire is to keep all patients and healthcare workers safe through easy access to critical medication safety information. For more information, visit https://www.rpharmy.com/

Contacts

Carrie Ward, PR for Rpharmy, 832-407-5347, [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.